Dynamic bias and its implications for GPCR drug discovery.
about
Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugs.GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning.
P2860
Dynamic bias and its implications for GPCR drug discovery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Dynamic bias and its implications for GPCR drug discovery.
@en
Dynamic bias and its implications for GPCR drug discovery.
@nl
type
label
Dynamic bias and its implications for GPCR drug discovery.
@en
Dynamic bias and its implications for GPCR drug discovery.
@nl
prefLabel
Dynamic bias and its implications for GPCR drug discovery.
@en
Dynamic bias and its implications for GPCR drug discovery.
@nl
P2093
P2860
P356
P1476
Dynamic bias and its implications for GPCR drug discovery.
@en
P2093
Martin C Michel
Richard A Bond
Roland Seifert
P2860
P2888
P356
10.1038/NRD3954-C3
P577
2014-10-17T00:00:00Z